Local Organisers
Prof Hannah Tamary
Dr Orna Steinberg Shemer
Molecular laboratory, Hematology Oncology division, Schneider Children’s Medical Centerof Israel and Felsenstein Medical Research Center, Tel Aviv University
Petah Tikva, Israel
How can I participate?
The applicants must send their application to Prof Hannah Tamary email: htamary@tauex.tau.ac.il, Dr Orna Steinberg-Shemer email: orna.steinberg@gmail.com and our COST Action Chair Prof Helen Papadaki, e-mail: coordinator@eunet-innochron.eu, before the deadline June 4th 2022.
The application should consist of:
– A brief C.V.
– A motivation letter stating the relevance to their research and the value to participate in the Training Course.
– A letter of support from a senior Researcher/Clinician (preferably but not necessarily related to the EuNet-INNOCHRON project) from their home Institution where they are affiliated to.
The applicants will be formally notified of the outcome of their application on June 7th 2022 at the latest.
Dear EuNet-INNOCHRON colleagues,
We are excited to announce the Call for Applications for our Training School on Molecular Diagnosis of Congenital Neutropenias!
The “Training School on Molecular Diagnosis of Congenital Neutropenias” will take place in Petah Tikva in Israel, 04-05 July 2022, with Prof Hannah Tamary’s and Orna Steinberg-Shemer’s as our Host/Local Organizers.
Don’t miss the opportunity to apply and attend the Training School with full reimbursement of the expenses by EuNet-INNOCHRON.
Because a limited number of trainees can attend, please see details on the application process as well as the agenda below.
For questions please contact the coordinators at coordinator@eunet-innochron.eu
Warm regards,
The Local Organizer
The Coordinators
Purpose of the Training School:
The Training School on molecular diagnosis of Congenital Neutropenias is organized by the COST Action CA18233 European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias (EuNet-INNOCHRON https://eunet-innochron.eu/). The Training School aims at covering aspects on molecular diagnosis on Congenital Neutropenias including molecular biology techniques such as Sanger Sequencing and NGS.The participating scientists will have the opportunity to expand their knowledge via interactive lectures from experts on aspects related to molecular diagnosis on Congenital Neutropenias, familiarize themselves with protocols, discuss, and get hands-on experience on performing sequencing and interpreting their results.
The host of the Training School is Prof Hannah Tamary’s and Orna Steinberg-Shemer’s Department in the Schneider Children’s Medical Center, Petah Tikva in Israel.
To offer a high-quality hands-on experience, a limited number of participants will be accepted.
Deadline for applications: June 4th, 2022
Application Process:
- The applicants must send their application to Prof Hannah Tamary email: htamary@tauex.tau.ac.il, Dr Orna Steinberg-Shemer email: orna.steinberg@gmail.com and our COST Action Chair Prof Helen Papadaki, e-mail: coordinator@eunet-innochron.eu, before the deadline June 4th 2022.
The application should consist of:
- A brief C.V.
- A motivation letter stating the relevance to their research and the value to participate in the Training Course.
- A letter of support from a senior Researcher/Clinician (preferably but not necessarily related to the EuNet-INNOCHRON project) from their home Institution where they are affiliated to.
- The applicants will be formally notified of the outcome of their application on June 7th 2022 at the latest.
Important Notes:
- The selected applicants will be sent a formal COST invitation to the email they have provided and instructions for reimbursement rules for the expenses regarding the whole travel.
- The selected participants will be reimbursed from the COST Action EuNet-INNOCHRON for travel costs and will get a fixed amount of daily allowance (for their accommodation, 2 meals/day and any public local transport).
[please refer to COST rules https://www.cost.eu/uploads/2022/03/Travel-Reimbursement-Rules_March-2022.pdf ] - To attend this face-to face Training School, participants are subject to the regulations of the Israeli National Health Authorities regarding the pandemic that are being constantly revised. https://corona.health.gov.il/en/abroad/arriving-foreign-nationals/
Day 1, july 4, 2022
10.00 – 10.05 Welcome
[Prof Shai Izraeli]
10.05 – 10.45 Introduction and overview of the molecular diagnosis of congenital neutropenias
[Dr Orna Steinberg-Shemer]
10.45 – 11.30 Molecular biology techniques [Sanger and NGS sequencing]
[Dr Orly Dgany]
11.30 – 12.00 Interpretation of sequence variants
[Dr Sharon Noy Lotan]
12.00 – 13.00 Lunch Break
14.00 – 16.00 Hands on training – session I [bone marrow morphology, Sanger sequencing, NGS panels, bioinformatics]
[trainers: lab team]
Day 2, july 5, 2022
10.00 – 12.00 Hands on training – session II [somatic panels]
[trainers: lab team]
12.00 – 12.30 Concluding lecture – the role of molecular diagnosis of congenital neutropenias and additional prolonged cytopenias
[Prof Hannah Tamary]
12.30 – 13.30 Lunch
Speakers and Teaching Team
|
Title |
Name |
Affiliation |
City |
Country |
|
Prof |
Shai Izraeli, MD, Phd |
Head of Hematology Oncology Division, Schneider Children’s Medical Center of Israel |
Petah Tikva |
Israel |
|
Prof |
Hannah Tamary, MD |
Hematology/Oncology Division, Schneider Children’s Medical Center of Israel |
Petah Tikva |
Israel |
|
Dr |
Orna Steinberg-Shemer, MD, MSc |
Hematology/Oncology Division, Schneider Children’s Medical Center of Israel |
Petah Tikva |
Israel |
|
Dr |
Orly Dgany, PhD |
Pediatric Hematology Laboratory, Felsenstein Medical Research Center |
Tel Aviv |
Israel |
|
Dr |
Sharon Noy Lotan, PhD |
Hematology/Oncology Division, Schneider Children’s Medical Center of Israel |
Petah Tikva |
Israel |
|
Ms |
Tanya Krasnov, MSc |
Hematology/Oncology Division, Schneider Children’s Medical Center of Israel |
Petah Tikva |
Israel |
Parameters related to chronic inflammation described in Task 2 will be investigated for their association with the development of cancers, CVD, AID in patients with likely-acquired and idiopathic CNP. The medical history and specific questionnaires will be used at diagnosis and during follow-up. Autoantibody profiling and cancer screening tests will be evaluated and monitored. WES data from Task 1 will be analysed for AID identification. Quantitative/qualitative activity of the heart will be recorded using electro/echocardiograms. Quantification of carotid arterial plaque by ultrasound for identification of atherosclerosis and evaluation of CVD risk will be also used. Routine PB biochemical parameters and specific biomarkers (such as troponins, natriuretic peptides and hsCRP) will be evaluated and associated with the inflammatory markers in CNP patients.
